Zacks Research Has Negative Estimate for CRL Q1 Earnings
Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) – Research analysts at Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for Charles River Laboratories International in a research report issued on Wednesday, March 12th. Zacks Research analyst R. Department now anticipates that the medical research company will earn $2.08 per share […]
Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) – Research analysts at Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for Charles River Laboratories International in a research report issued on Wednesday, March 12th. Zacks Research analyst R. Department now anticipates that the medical research company will earn $2.08 per share […]
